NYSE · US Equities - Dividend & Fundamental · USA
The companies inside AKRE trade 5% below what we estimate they are worth. We could give a verdict on 79% of the fund's weight: 19 holdings as reported to the SEC at 31 Jul 2026.
Where the money is: 27% in companies in the buy zone, 12% about fairly valued, 40% overvalued, 21% without a verdict.
The ten largest holdings, with our verdict on each:
Its expense ratio is 0.98% a year: on $10,000 held flat that is $980 over 10 years and $1,960 over 20.